abrdn plc Has $2.54 Million Stake in Bath & Body Works, Inc. (NYSE:BBWI)

abrdn plc increased its position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) by 7.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 60,226 shares of the company’s stock after purchasing an additional 4,384 shares during the period. abrdn plc’s holdings in Bath & Body Works were worth $2,538,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Boyd Watterson Asset Management LLC OH bought a new stake in Bath & Body Works during the fourth quarter worth about $28,000. Capital Advisors Ltd. LLC boosted its position in shares of Bath & Body Works by 50.4% during the 4th quarter. Capital Advisors Ltd. LLC now owns 1,065 shares of the company’s stock worth $29,000 after acquiring an additional 357 shares in the last quarter. First Horizon Advisors Inc. increased its stake in Bath & Body Works by 151.4% in the third quarter. First Horizon Advisors Inc. now owns 1,149 shares of the company’s stock valued at $36,000 after acquiring an additional 692 shares during the last quarter. Signaturefd LLC lifted its stake in Bath & Body Works by 60.7% during the fourth quarter. Signaturefd LLC now owns 1,289 shares of the company’s stock worth $54,000 after purchasing an additional 487 shares during the last quarter. Finally, AlphaCentric Advisors LLC bought a new position in shares of Bath & Body Works in the 3rd quarter valued at $56,000. 96.34% of the stock is currently owned by institutional investors.

Insider Activity at Bath & Body Works

In other news, CFO Wendy C. Arlin sold 1,625 shares of the firm’s stock in a transaction on Tuesday, March 28th. The shares were sold at an average price of $38.29, for a total transaction of $62,221.25. Following the sale, the chief financial officer now owns 91,072 shares in the company, valued at approximately $3,487,146.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.19% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

BBWI has been the subject of a number of recent research reports. Morgan Stanley dropped their target price on Bath & Body Works from $76.00 to $61.00 in a research report on Friday, May 19th. Cowen raised their price target on shares of Bath & Body Works from $45.00 to $52.00 and gave the company an “outperform” rating in a research note on Thursday, February 16th. UBS Group lowered Bath & Body Works from a “buy” rating to a “neutral” rating in a research note on Wednesday, March 29th. Credit Suisse Group increased their target price on shares of Bath & Body Works from $42.00 to $46.00 and gave the company a “neutral” rating in a research report on Friday, February 24th. Finally, Barclays boosted their price target on shares of Bath & Body Works from $37.00 to $41.00 in a research report on Sunday. One research analyst has rated the stock with a sell rating, nine have given a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $46.45.

Bath & Body Works Stock Up 1.0 %

Shares of NYSE:BBWI opened at $38.51 on Wednesday. The business’s 50 day moving average is $35.30 and its 200 day moving average is $39.56. Bath & Body Works, Inc. has a 12-month low of $25.75 and a 12-month high of $49.55. The stock has a market cap of $8.81 billion, a price-to-earnings ratio of 12.19, a PEG ratio of 0.99 and a beta of 1.70.

Bath & Body Works (NYSE:BBWI – Get Rating) last released its quarterly earnings results on Thursday, May 18th. The company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.07. Bath & Body Works had a net margin of 9.67% and a negative return on equity of 29.65%. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same period last year, the firm earned $0.64 earnings per share. The firm’s revenue was down 3.7% on a year-over-year basis. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 2.98 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 16th. Shareholders of record on Friday, June 2nd will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.08%. The ex-dividend date is Thursday, June 1st. Bath & Body Works’s payout ratio is 25.32%.

About Bath & Body Works

(Get Rating)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.